Cellular delivery of MRI contrast agents

Chemistry and Biology

Volumn 11, Issue 3, 2004, Pages 301-307

  Allen, Matthew J ^a,c   MacRenaris, Keith W ^c   Venkatasubramanian, P N ^b   Meade, Thomas J ^a,c  

^a NORTHWESTERN UNIVERSITY   (United States)

^b ENH Research Institute   (United States)

^c CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CHELATING AGENT; CONTRAST MEDIUM; LANTHANIDE; OCTANOL; WATER;

ANIMAL; ARTICLE; CELL LINE; CELL MEMBRANE PERMEABILITY; CELL STRAIN 3T3; CHEMICAL STRUCTURE; CHEMISTRY; DOG; DRUG EFFECT; INSTRUMENTATION; MOUSE; NUCLEAR MAGNETIC RESONANCE IMAGING; RAT; SYNTHESIS;

ANIMALS; ARGININE; CELL LINE; CELL MEMBRANE PERMEABILITY; CHELATING AGENTS; CONTRAST MEDIA; DOGS; LANTHANOID SERIES ELEMENTS; MAGNETIC RESONANCE IMAGING; MICE; MOLECULAR STRUCTURE; NIH 3T3 CELLS; OCTANOLS; RATS; WATER;

ANIMALIA; CANIS FAMILIARIS;

EID: 6444229327     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2004.03.003     Document Type: Article

References (28)

1. Haraguchi T. Live cell imaging. approaches for studying protein dynamics in living cells Cell Struct. Funct. 27:2002;333-334.
2. Morimoto K., Shimizu T., Furukawa K., Morio H., Kurosawa H., Shirasawa T. Transgenic expression of the EXT2 gene in developing chondrocytes enhances the synthesis of heparan sulfate and bone formation in mice. Biochem. Biophys. Res. Commun. 292:2002;999-1009.
3. Cherry S.R. Fundamentals of positron emission tomography and applications in preclinical drug development. J. Clin. Pharmacol. 41:2001;482-491.
4. Ruffins S.W., Jacobs R.E., Fraser S.E. Towards a Tralfamadorian view of the embryo. multidimensional imaging of development Curr. Opin. Neurobiol. 12:2002;580-586.
5. Merbach A.E., Toth E. The Chemistry of Contrast Agents in Medical Magnetic Resonance Imaging. 2001;John Wiley & Sons, Ltd, New York.
6. Jacobs R.E., Ahrens E.T., Meade T.J., Fraser S.E. Looking deeper into vertebrate development. Trends Cell Biol. 9:1999;73-76.
7. Hueber M.M., Staubli A.B., Kustedjo K., Gray M.H.B., Shih J., Fraser S.E., Jacobs R.E., Meade T.J. Fluorescently detectable magnetic resonance imaging agents. Bioconjug. Chem. 9:1998;242-249.
8. Allen M.J., Meade T.J. Synthesis and visualization of a membrane permeable MRI contrast agent. J. Biol. Inorg. Chem. 8:2003;746-750.
9. Bhorade R., Weissleder R., Nakakoshi T., Moore A., Tung C.-H. Macrocyclic chelators with paramagnetic cations are internalized into mammalian cells via a HIV-Tat derived membrane translocation peptide. Bioconjug. Chem. 11:2000;301-305.
10. Wunderbaldinger P., Josephson L., Weissleder R. Tat peptide directs enhanced clearance and hepatic permeability of magnetic nanoparticles. Bioconjug. Chem. 13:2002;264-268.
11. Lewin M., Carlesso N., Tung C.-H., Tang X.-W., Cory D., Scadden D.T., Weissleder R. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat. Biotechnol. 18:2000;410-414.
12. Josephson L., Tung C.-H., Moore A., Weissleder R. High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates. Bioconjug. Chem. 10:1999;186-191.
13. Dodd C.H., Hsu H.C., Chu W.J., Yang P., Zhang H.G., Mountz J.D., Zinn K., Forder J., Josephson L., Weissleder R.et al. Normal T-cell response and in vivo magnetic resonance imaging of T cells loaded with HIV transactivator- peptide-derived superparamagnetic nanoparticles. J. Immunol. Methods. 256:2001;89-105.
14. Kayyem J.F., Kumar R.M., Fraser S.E., Meade T.J. Receptor-targeted co-transport of DNA and magnetic resonance contrast agents. Chem. Biol. 2:1995;615-620.
15. Heckl S., Debus J., Jenne J., Pipkorn R., Waldeck W., Spring H., Rastert R., Von der Lieth C.W., Braun K. CNN-Gd3+ enables cell nucleus molecular imaging of prostate cancer cells. the last 600 nm Cancer Res. 62:2002;7018-7024.
16. Louie A.Y., Huber M.M., Ahrens E.T., Rothbacher U., Moats R., Jacobs R.E., Fraser S.E., Meade T.J. In vivo visualization of gene expression using magnetic resonance imaging. Nat. Biotechnol. 18:2000;321-325.
17. Moats R.A., Fraser S.E., Meade T.J. A "smart" magnetic resonance imaging agent that reports on specific enzymic activity. Angew. Chem. Int. Ed. Engl. 36:1997;726-728.
18. Mitchell D.J., Kim D.T., Steinman L., Fathman C.G., Rothbard J.B. Polyarginine enters cells more efficiently than other polycationic homopolymers. J. Pept. Res. 56:2000;318-325.
19. Futaki S., Suzuki T., Ohashi W., Yagami T., Tanaka S., Ueda K., Sugiura Y. Arginine-rich peptides. an abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery J. Biol. Chem. 276:2001;5836-5840.
20. Kates S.A., Albericio F. Solid-Phase Synthesis. A Practical Guide:2000;Marcel Dekker, Inc, New York.
21. Gabriel T.F. Simple, rapid method for converting a peptide from one salt form to another. Int. J. Pept. Protein Res. 30:1987;40-43.
22. Cornish J., Callon K.E., Lin C.Q.X., Xiao C.L., Mulvey T.B., Cooper G.J.S., Reid I.R. Trifluoroacetate, a contaminant in purified proteins, inhibits proliferation of osteoblasts and chondrocytes. Am. J. Physiol. 277:1999;E779-E783.
23. Freshney R.I. Culture of Animal Cells. A Manual of Basic Technique Fourth Edition:2000;John Wiley & Sons, Inc, New York.
24. Goodwin J.T., Conradi R.A., Ho N.F.H., Burton P.S. Physicochemical determinants of passive membrane permeability. role of solute hydrogen-bonding potential and volume J. Med. Chem. 44:2001;3721-3729.
25. Kramer S.D. Absorption prediction from physicochemical parameters. Pharm. Sci. Technol. Today. 2:1999;373-380.
26. Conradi R.A., Hilgers A.R., Ho N.F.H., Burton P.S. The influence of peptide structure on transport across Caco-2 cells. Pharm. Res. 8:1991;1453-1460.
27. Harris D.C. Quantitative Chemical Analysis. Fourth Edition:1995;W.H. Freeman and Company, New York.
28. Allen M.J., Meade T.J. Synthesis and visualization of a membrane permeable MRI contrast agent. J. Biol. Inorg. Chem. 8:2003;746-750.